![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: IQCE |
Gene summary for IQCE |
![]() |
Gene information | Species | Human | Gene symbol | IQCE | Gene ID | 23288 |
Gene name | IQ motif containing E | |
Gene Alias | 1700028P05Rik | |
Cytomap | 7p22.3 | |
Gene Type | protein-coding | GO ID | GO:0007275 | UniProtAcc | A0A087WX45 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23288 | IQCE | P83T-E | Human | Esophagus | ESCC | 1.52e-05 | 1.83e-01 | 0.1738 |
23288 | IQCE | P89T-E | Human | Esophagus | ESCC | 1.58e-02 | 1.74e-01 | 0.1752 |
23288 | IQCE | P107T-E | Human | Esophagus | ESCC | 2.53e-07 | 1.36e-01 | 0.171 |
23288 | IQCE | P127T-E | Human | Esophagus | ESCC | 1.40e-07 | 9.88e-02 | 0.0826 |
23288 | IQCE | P128T-E | Human | Esophagus | ESCC | 1.79e-08 | 2.26e-01 | 0.1241 |
23288 | IQCE | P130T-E | Human | Esophagus | ESCC | 1.50e-16 | 3.42e-01 | 0.1676 |
23288 | IQCE | HCC1_Meng | Human | Liver | HCC | 2.02e-15 | -4.09e-02 | 0.0246 |
23288 | IQCE | HCC2_Meng | Human | Liver | HCC | 5.72e-20 | 1.11e-01 | 0.0107 |
23288 | IQCE | HCC2 | Human | Liver | HCC | 1.08e-02 | 2.59e+00 | 0.5341 |
23288 | IQCE | S015 | Human | Liver | HCC | 6.37e-06 | 3.01e-01 | 0.2375 |
23288 | IQCE | S016 | Human | Liver | HCC | 2.70e-02 | 1.99e-01 | 0.2243 |
23288 | IQCE | S027 | Human | Liver | HCC | 8.28e-14 | 8.42e-01 | 0.2446 |
23288 | IQCE | S028 | Human | Liver | HCC | 1.18e-19 | 7.63e-01 | 0.2503 |
23288 | IQCE | S029 | Human | Liver | HCC | 1.60e-11 | 5.74e-01 | 0.2581 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00487367 | Esophagus | ESCC | appendage development | 98/8552 | 172/18723 | 1.83e-03 | 8.37e-03 | 98 |
GO:00601737 | Esophagus | ESCC | limb development | 98/8552 | 172/18723 | 1.83e-03 | 8.37e-03 | 98 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
IQCE | SNV | Missense_Mutation | rs555990190 | c.506N>T | p.Thr169Met | p.T169M | protein_coding | deleterious(0) | probably_damaging(0.981) | TCGA-AR-A5QQ-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | carboplatin | PD | |
IQCE | insertion | Frame_Shift_Ins | novel | c.1906_1907insAAATTACT | p.Arg636LysfsTer40 | p.R636Kfs*40 | protein_coding | TCGA-A7-A0CG-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |||
IQCE | insertion | Frame_Shift_Ins | novel | c.1907_1908insAGGCTGCTGTAAACCTCAGA | p.Arg637GlyfsTer43 | p.R637Gfs*43 | protein_coding | TCGA-A7-A0CG-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |||
IQCE | insertion | Frame_Shift_Ins | novel | c.283_284insG | p.Ser95CysfsTer18 | p.S95Cfs*18 | protein_coding | TCGA-A8-A079-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | 5-fluorouracil | SD | |||
IQCE | insertion | Nonsense_Mutation | novel | c.284_285insAGTGGAACCAGATCTGGACCCCGTTCTGTGAGATCTGG | p.Pro96ValfsTer10 | p.P96Vfs*10 | protein_coding | TCGA-A8-A079-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | 5-fluorouracil | SD | |||
IQCE | insertion | Frame_Shift_Ins | novel | c.1108_1109insACAGGAGGGAAGATGTGCAGAGTCGTTTGAGTCC | p.Ala370AspfsTer122 | p.A370Dfs*122 | protein_coding | TCGA-BH-A0BM-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD | |||
IQCE | SNV | Missense_Mutation | novel | c.501N>A | p.Met167Ile | p.M167I | protein_coding | deleterious(0) | possibly_damaging(0.611) | TCGA-C5-A8XJ-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Chemotherapy | cisplatin | SD | |
IQCE | SNV | Missense_Mutation | rs775017409 | c.363N>C | p.Lys121Asn | p.K121N | protein_coding | deleterious(0) | possibly_damaging(0.802) | TCGA-IR-A3LK-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Chemotherapy | cisplatin | PD | |
IQCE | SNV | Missense_Mutation | rs779690833 | c.1217C>T | p.Ala406Val | p.A406V | protein_coding | deleterious(0.05) | benign(0.03) | TCGA-AA-3492-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
IQCE | SNV | Missense_Mutation | novel | c.1621N>A | p.Val541Ile | p.V541I | protein_coding | tolerated(0.16) | benign(0.071) | TCGA-AA-3860-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | folinic | CR |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |